106 related articles for article (PubMed ID: 15765117)
21. Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.
Gahrton G; Iacobelli S; Bandini G; Björkstrand B; Corradini P; Crawley C; Hegenbart U; Morgan G; Kröger N; Schattenberg A; Schönland SO; Verdonck LF; Volin L; de Witte T; Niederwieser D;
Haematologica; 2007 Nov; 92(11):1513-8. PubMed ID: 18024400
[TBL] [Abstract][Full Text] [Related]
22. Update on thalassemia: clinical care and complications.
Cunningham MJ
Pediatr Clin North Am; 2008 Apr; 55(2):447-60, ix. PubMed ID: 18381095
[TBL] [Abstract][Full Text] [Related]
23. Successful management of mixed chimerism after bone marrow transplant in beta-thalassemia major.
Kropshofer G; Sopper S; Steurer M; Schwinger W; Crazzolara R
Am J Hematol; 2016 Sep; 91(9):E357-8. PubMed ID: 27239048
[No Abstract] [Full Text] [Related]
24. Hematopoietic transplantation for bone marrow failure syndromes and thalassemia.
Sevilla J; Fernández-Plaza S; Diaz MA; Madero L;
Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S17-21. PubMed ID: 15812523
[TBL] [Abstract][Full Text] [Related]
25. Pericarditis occurring with engraftment syndrome in a thalassemic patient.
Pakakasama S; Wanitkun S; Hongeng S
Bone Marrow Transplant; 2004 Nov; 34(9):819-20. PubMed ID: 15361914
[No Abstract] [Full Text] [Related]
26. Survival, mortality, and complications in patients with beta-thalassemia major in northern Taiwan.
Chern JP; Su S; Lin KH; Chang SH; Lu MY; Jou ST; Lin DT; Ho WL; Lin KS
Pediatr Blood Cancer; 2007 May; 48(5):550-4. PubMed ID: 16972241
[TBL] [Abstract][Full Text] [Related]
27. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
28. Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients.
La Nasa G; Littera R; Locatelli F; Giardini C; Ventrella A; Mulargia M; Vacca A; Orrù N; Orrù S; Piras E; Giustolisi G; Lisini D; Nesci S; Caocci G; Carcassi C
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1358-68. PubMed ID: 17950922
[TBL] [Abstract][Full Text] [Related]
29. Marrow aplasia developing 13 years after HLA-identical sibling allogeneic transplantation for chronic myeloid leukaemia: successful treatment with antithymocyte globulin and peripheral blood stem cell infusion from the original donor.
O'Donghaile D; Hayden PJ; McCarron SL; Doyle EM; Lawler M; Browne PV; Conneally E; Vandenberghe E; McCann SR
Eur J Haematol; 2006 Mar; 76(3):258-60. PubMed ID: 16451399
[TBL] [Abstract][Full Text] [Related]
30. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
31. [Allogeneic bone marrow transplantation in beta thalassemia].
van den Berg H; Bernini LF; Sukhai RN; Vossen JM
Ned Tijdschr Geneeskd; 1987 Jan; 131(1):18-21. PubMed ID: 3547150
[No Abstract] [Full Text] [Related]
32. Gaucher-like cells in beta-thalassemia patient after bone marrow transplantation.
Gesundheit B; Or R; Amar A; Filon D; Gail A
J Pediatr Hematol Oncol; 2006 Apr; 28(4):203-4. PubMed ID: 16679915
[No Abstract] [Full Text] [Related]
33. Marrow transplantation in advanced thalassemic patients using a new conditioning regimen.
Nourani Khojasteh H; Zakerinia M; Ramzi M; Haghsenas M
Transplant Proc; 2001 Aug; 33(5):2862. PubMed ID: 11498191
[No Abstract] [Full Text] [Related]
34. Allogeneic stem cell transplantation from unrelated donor for class 3 beta-thalassemia major using reduced-intensity conditioning regimen.
Zhu KE; Gu J; Zhang T
Bone Marrow Transplant; 2006 Jan; 37(1):111-2. PubMed ID: 16258532
[No Abstract] [Full Text] [Related]
35. [Treatment of bone cyst by transplantation of autologous bone marrow combined with allograft bone].
Deng G; Ling Q; Li T
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Aug; 21(8):801-3. PubMed ID: 17882871
[TBL] [Abstract][Full Text] [Related]
36. Bone mineral density in children and young adults with beta-thalassemia major conventionally treated.
Christoforidis A; Hatzipantelis E; Tsatra I; Kazantzidou E; Katzos G; Athanassiou-Metaxa M
Pediatr Blood Cancer; 2006 Jul; 47(1):113-4; author reply 115. PubMed ID: 16602118
[No Abstract] [Full Text] [Related]
37. The treatment of thalassemia--slow progress and new dilemmas.
Weatherall DJ
N Engl J Med; 1993 Sep; 329(12):877-9. PubMed ID: 7689172
[No Abstract] [Full Text] [Related]
38. Images in clinical medicine. Successful treatment of severe thalassemia.
Muretto P; Angelucci E
N Engl J Med; 1999 Jul; 341(2):92. PubMed ID: 10395633
[No Abstract] [Full Text] [Related]
39. Successful treatment of JMML with related bone marrow transplantation after reduced-intensity conditioning.
Koyama M; Nakano T; Takeshita Y; Sakata A; Sawada A; Yasui M; Okamura T; Inoue M; Kawa K
Bone Marrow Transplant; 2005 Sep; 36(5):453-4; author reply 454. PubMed ID: 15968292
[No Abstract] [Full Text] [Related]
40. Impact of pretransplant splenectomy on patients with beta-thalassemia major undergoing a matched-related allogeneic stem cell transplantation.
Mathews V; George B; Lakshmi KM; Viswabandya A; John JM; Sitaram U; Daniel D; Chandy M; Srivastava A
Pediatr Transplant; 2009 Mar; 13(2):171-6. PubMed ID: 18482210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
